Inventor · disambiguated record
John V. Heymach
Also filed as: HEYMACH JOHN · HEYMACH JOHN V
4 granted patents·27 pending applications·13 citations·filing 2005–2025
66Inventor score
Top patents by PatentIndex Score
31 records- 0176US11446302B2Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutationsUNIV TEXAS·Filed 2017·Granted Sep 20, 2022·2 cites·18 claims
- 0272US8428317B2Binned micro-vessel density methods and apparatusKIMIA BENJAMIN·Filed 2007·Granted Apr 23, 2013·11 cites·24 claims
- 0360US2024011103A1Molecular subtyping of small cell lung cancer to predict therapeutic responsesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0459US2023233563A1Compounds with anti-tumor activity against cancer cells bearing egfr or her2 exon 20 mutationsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0559US2025044293A1Personalized ranking and identification of onco-reactive t cell receptors and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0657US2025312348A1Compounds with anti-tumor activity against cancer cells bearing egfr or her2 exon 20 insertionsUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0754US11732306B2Molecular subtyping of small cell lung cancer to predict therapeutic responsesUNIV TEXAS·Filed 2020·Granted Aug 22, 2023·0 cites·14 claims
- 0852US2024374597A1Methods and compositions for treatment of kras mutant cancerUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0950US2024108623A1Methods of treating cancer with poziotinibUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1049US11365189B2Heterocyclic inhibitors of tyrosine kinaseUNIV TEXAS·Filed 2020·Granted Jun 21, 2022·0 cites·30 claims
- 1149US2022143023A1Compounds with anti-tumor activity against cancer cells bearing egfr or her2 exon 20 insertionsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1248US2024384350A1Methods of treating cancer with kinase inhibitorsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1348US2018220984A1Medical Imaging Methods And Apparatus For Diagnosis And Monitoring Of Diseases And Uses ThereforBIO TREE SYSTEMS INC·Filed 2018·Application pending·0 cites
- 1447US2022380765A1Targeting nonsense-mediated decay to activate p53 pathway for the treatment of cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1547US2024150848A1Methods and systems for diagnosis, classification, and treatment of small cell lung cancer and other high-grade neuroendocrine carcinomasUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1646US2022194940A1Heterocyclic inhibitors of tyrosine kinaseUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1746US2009328239A1Blood vessel imaging and uses thereforBIO TREE SYSTEMS INC·Filed 2009·Application pending·0 cites
- 1845US2023121116A1Use of quinazoline-based tyrosine kinase inhibitors for the treatment of cancers with nrg1 fusionsUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1945US2023112470A1Use of egfr/her2 tyrosine kinase inhibitors and/or her2/her3 antibodies for the treatment of cancers with nrg1 fusionsUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2045US2023069749A1Use of poziotinib for the treatment of cancers with nrg1 fusionsUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2145US2022041751A1Combination therapy for the treatment of cancerUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2244US2023405117A1Methods and systems for classification and treatment of small cell lung cancerUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2343US2022193074A1Compounds with anti-tumor activity against cancer cells bearing tyrosine kinase inhibitor resistant egfr mutationsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2442US2022175778A1Compounds with anti-tumor activity against cancer cells bearing her2 exon 21 insertionsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2542US2021361655A1Compounds with anti-tumor activity against cancer cells bearing her2 exon 19 mutationsUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2642US2022265847A1Methods and compositions for treating non-small cell lung cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2742US2009005693A1Medical Imaging Methods and Apparatus for Diagnosis and Monitoring of Diseases and Uses ThereforBIOTREE SYSTEMS INC·Filed 2005·Application pending·0 cites
- 2841US2022175779A1Compounds against cancer bearing tyrosine kinase inhibitor resistant egfr mutationsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2941US2021015819A1Methods for treatment of cancers with egfr activating mutationsUNIV TEXAS·Filed 2019·Application pending·0 cites
- 3037US2013230511A1Biomarkers for response to tyrosine kinase pathway inhibitors in cancerUNIV TEXAS·Filed 2013·Application pending·0 cites
- 3136US2014155397A1Emt signatures and predictive markers and method of using the sameHEYMACH JOHN V·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John V. Heymach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →